DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Inspire scientists and collaborators are presenting information from the Phase 4 program with AzaSite® (azithromycin ophthalmic solution) 1% in two electronic poster presentations at the 2009 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting April 3 - 8, 2009 in San Francisco, CA.
